Background
Pneumonia accounts for more fatalities in children globally than any other infectious disease [
1]. In 2010, 120 million cases of pneumonia were recorded in children under 5 years of age. Treatment includes supplemental oxygen [
2]; however, the availability of medical oxygen is unreliable in many low- to middle-income countries (LMICs) [
3]. Our study took place in Kenya, a high burden country for pediatric pneumonia, with widespread oxygen insecurity. The under-five mortality rate in Kenya is approximately 4.6%, with 68,882 deaths annually [
1]. Pneumonia accounts for 16% of child mortality, the second leading cause of death in children [
2].
Hypoxemia, a blood oxygen saturation (SpO
2) < 90%, increases the risk of mortality in children with pneumonia fivefold [
4,
5]. Therefore, timely diagnosis and treatment of hypoxemia are essential to optimize patient outcomes [
6]. Oxygen cylinders and oxygen concentrators are standard oxygen delivery methods employed in LMICs [
6,
7]. However, cylinders are costly to transport, require regular replenishment [
8], and are only feasible as a method of oxygen delivery where there is a reliable supply chain [
9]. Oxygen concentrators [
10] are less costly and more convenient than cylinders; however, they depend on a reliable source of electricity [
9].
Power insecurity in healthcare facilities in LMICs remains a critical barrier to providing reliable oxygen delivery [
11]. Power interruptions in many areas are frequent and long-lasting [
3]. One solution may be to store oxygen in a reservoir while power is available, for use during power outages. Currently, there are a limited number of devices capable of bridging power outages to deliver continuous oxygen [
6,
7,
12]. High-pressure oxygen storage systems are associated with safety hazards and may be vulnerable to leakage from fittings. On the other hand, low pressure reservoirs (LPRs) occupy a large volume and have restricted mobility [
12]. LPRs are often housed outside of the ward and may not be feasibly installed in all facilities [
13]. A medium-pressure reservoir (MPR) may have the benefits of safety, ruggedness, and compact size.
The objectives of our study were: (1) to design and test an MPR in a controlled pre-clinical environment; (2) to establish the feasibility of using the MPR device in two low-resource hospitals; (3) to determine whether the MPR was capable of delivering an uninterrupted oxygen supply during power outages; and (4) to assess end-user (health worker) feedback on the MPR oxygen delivery system.
Methods
Pre-clinical design
The design of the MPR sought to balance the need for continuous supply of oxygen with the cost, complexity, and ease of use of the storage device. An ideal MPR solution would maximize stored oxygen volume while minimizing the system’s physical footprint and operational complexity while being compatible with all commercial oxygen concentrators. Considerations included in the design were: (1) preference for off-the-shelf commercial products to capitalize on economies of scale costing and manufacturer component durability testing; (2) appropriate boost compressor size so it was not choked by output specifications of the oxygen concentrator and would reliably operate up to our maximum pressure without stalling; (3) safety of operation with respect to ignition risk due to storing high concentration oxygen at elevated pressure. A more complete description of the design considerations is included in the online supporting materials.
Clinical pilot study design and setting
This was an observational case series piloting the MPR on a small number of children with hypoxemia. Two rural hospitals in Kenya were chosen based on their high volumes of pediatric inpatients and unreliable electricity for deployment of the MPR oxygen delivery system: Ahero Hospital (Kisumu County), and Suba Hospital (Homa Bay County). We have previously reported on the availability and reliability of medical oxygen and electrical power at these and other facilities in the area [
3].
Clinical definitions
Tachypnea and tachycardia were defined as respiratory rate or heart rate above the 99th percentile for age, respectively [
14]. The Signs of Inflammation in Children that Kill (SICK) score is a composite severity-of-illness instrument used to predict the risk of subsequent mortality [
15]. Non-invasive clinical assessment of patients’ respiratory rate, heart rate, capillary refill time, SpO
2, systolic blood pressure and temperature are used to calculate the SICK score [
16]. Patients with SICK scores exceeding 2.3 are at high risk of mortality [
17].
Inclusion, exclusion and early discontinuation criteria
Patients were enrolled in the study if they met the following inclusion criteria: (1) age > 1 year and < 16 years; (2) hypoxemia (SpO2 < 90%); (3) admission to hospital warranted by the attending physician; and (4) provided written informed consent from the child’s legal guardian, and assent from children > 7 years of age. Exclusion or early discontinuation from the MPR occurred if: (1) patient SICK scores exceeded 2.3; (2) they required an oxygen flowrate > 2 L/min; or (3) an alarm indicated that reservoir was nearly depleted or oxygen concentration was < 82%.
Equipment and patient monitoring
The MPR instrument was monitored using near-continuous measurements of the flowrate (Honeywell Zephyr, Charlotte, NC), tank pressure (Honeywell PX3, Charlotte, NC), and oxygen quality (Compass Controls Manufacturing, 120-G, Lenexa, KS). Grid power reliability was assessed using a customized enVision 23,010 IC power monitor (Ametek®, Knightdale, NC). Measurements were logged every 0.1 min and stored for future analysis at the end of the trial. Nurses monitored patient vital signs as well as oxygen saturation every four hours (Rad-5® oximeter, Masimo Corp., Irvine, CA).
Satisfaction questionnaire
A 10-item satisfaction questionnaire was designed to systematically evaluate the user feedback on the device. The questionnaire was administered to a convenience sample of users of the device at the end of the clinical trial and included information on ease of use, perceived strengths and limitations, and overall appraisal of the MPR.
Discussion
Here we demonstrate the potential utility of a novel MPR that can bridge power outages to deliver a continuous oxygen supply. After pre-clinical development and testing, the MPR was deployed in two rural hospitals in Kenya, demonstrating feasibility for use on resource-limited pediatrics wards. Real-world power outages lasting > 30 min were seamlessly and automatically bridged by the MPR. User feedback was uniformly positive. Our study supports further development of the MPR device and encourages larger non-inferiority trials.
Hypoxemia is a severe and life-threatening complication of pneumonia. The median prevalence of hypoxemia in children with pneumonia requiring hospitalisation is 13% [
23]. The case-fatality rate of pneumonia ranges from 3 to 15%, with a fivefold higher odds of death in children with hypoxemia [
24]. In our study, 9/88 (10%) of screened patients were hypoxemic, and 1/9 (11%) of hypoxemic patients died, consistent with these data.
More than half of the patients in our study experienced one or more power outages, all of which were successfully bridged by the MPR (Table
2). Most power outages occurred at a critical time of oxygen dependency, such that clinical consequences may have been severe without backup flow from the MPR. Two power interruptions lasted > 30 min and were potentially life-threatening. A previous study on power insecurity in 12 sub-Saharan African countries found that electricity was fully available in only 35% of the 231 healthcare facilities assessed [
25]. We previously showed that power was unavailable for a median of 7% of the time in Kenyan facilities [
3]. In light of these findings, tenuous electrical supply in our study and previous studies highlights the need for interventions like the MPR.
Previous studies have assessed the use of high-pressure and low-pressure oxygen storage reservoirs in pre-clinical studies [
12,
13,
26]. In hospitals where there is a reliable supply chain from an oxygen plant, high-pressure oxygen cylinders are the standard. However, a previous study in Uganda found that only 10% of nurses showed adequate skills in operating a high-pressure oxygen cylinder [
26] and tightening of high-pressure mechanical fittings requires considerable manual strength [
27]. Our MPR was user-friendly and did not require manual intervention from the ward nurses. Problems with low-pressure oxygen cylinders are associated with the size of the reservoir. Space requirements are considerable, and often lead to the relocation of the low-pressure reservoir outside the hospital ward [
13]. In contrast, the MPR was maneuverable and integrated well in the clinical workflow. Thus, medium-pressure oxygen storage methods have the potential to overcome many of the limitations associated with high- and low-pressure oxygen cylinders.
There are several limitations to our study. The design was a pilot study that did not have a control group and was not statistically powered to demonstrate efficacy of the MPR. Our conclusions are therefore limited to feasibility of the MPR and its ability to bridge power outages on resource-limited pediatrics wards. We included two health facilities; however, a wider sampling of hospitals and health centres, across a range of available grid electricity, would be desirable to assess the ideal use case for the MPR. The cut off for the SICK score excluded the sickest patients and limited our ability to know how this intervention could impact outcomes in that cohort. Our study was limited to public facilities whereas non-state providers are increasingly present in low-income settings; our conclusions should therefore be extrapolated with caution to private health care facilities. The device described in this study is an engineering sample designed to test the feasibility of providing continuous oxygen through power outages. A commercial product is being developed with cost appropriate to LMICs being a consideration. The return on investment over the lifetime of the device should be comparable to the cost of oxygen cylinders and the logistics to deliver them. A formal cost-effectiveness analysis would be of interest, but is beyond the scope of the current manuscript.
Conclusion
Our MPR mitigates the risks of power insecurity and may improve the standard of care for hypoxemic pediatric patients in resource-limited settings. This device is likely to have the highest impact in high-volume health centers with frequent power interruptions, and it may not be suitable for large district hospitals. Further studies into where the MPR proves most effective are warranted.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.